EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:749553 - daclizumab
| ChEBI ID | CHEBI:749553 |
| ChEBI Name | daclizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| daclizumab (CHEBI:749553) has role anti-anaemic agent (CHEBI:75835) |
| daclizumab (CHEBI:749553) has role anti-asthmatic agent (CHEBI:65023) |
| daclizumab (CHEBI:749553) has role anti-HIV agent (CHEBI:64946) |
| daclizumab (CHEBI:749553) has role anti-inflammatory agent (CHEBI:67079) |
| daclizumab (CHEBI:749553) has role antineoplastic agent (CHEBI:35610) |
| daclizumab (CHEBI:749553) has role antipsoriatic (CHEBI:50748) |
| daclizumab (CHEBI:749553) has role hypoglycemic agent (CHEBI:35526) |
| daclizumab (CHEBI:749553) has role immunosuppressive agent (CHEBI:35705) |
| daclizumab (CHEBI:749553) has role ophthalmology drug (CHEBI:66981) |
| daclizumab (CHEBI:749553) has role renoprotective agent (CHEBI:231911) |
| daclizumab (CHEBI:749553) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Daclizumab | ChEMBL |
| Daclizumab beta | ChEMBL |
| RO 24-7375 | ChEMBL |
| RO-24-7375 | ChEMBL |
| Brand Names | Source |
|---|---|
| Zenapax | ChEMBL |
| Zinbryta | ChEMBL |